Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 01-Dec 2023. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 5287907014 | Netupitant 300 mg and palonosetron (as palonosetron hydrochloride) 500 microgram oral capsule | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 5287908016 | Product containing precisely netupitant 300 milligram and palonosetron (as palonosetron hydrochloride) 500 microgram/1 each conventional release oral capsule (clinical drug) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Netupitant 300 mg and palonosetron (as palonosetron hydrochloride) 500 microgram oral capsule | Is a | Product containing only netupitant and palonosetron in oral dose form (medicinal product form) | true | Inferred relationship | Some | ||
| Netupitant 300 mg and palonosetron (as palonosetron hydrochloride) 500 microgram oral capsule | Has manufactured dose form | Oral capsule | true | Inferred relationship | Some | ||
| Netupitant 300 mg and palonosetron (as palonosetron hydrochloride) 500 microgram oral capsule | Has unit of presentation | Capsule (unit of presentation) | true | Inferred relationship | Some | ||
| Netupitant 300 mg and palonosetron (as palonosetron hydrochloride) 500 microgram oral capsule | Plays role | Antiemetic therapeutic role (role) | false | Inferred relationship | Some | ||
| Netupitant 300 mg and palonosetron (as palonosetron hydrochloride) 500 microgram oral capsule | Has precise active ingredient | Palonosetron hydrochloride (substance) | true | Inferred relationship | Some | 1 | |
| Netupitant 300 mg and palonosetron (as palonosetron hydrochloride) 500 microgram oral capsule | Has basis of strength substance (attribute) | Palonosetron (substance) | true | Inferred relationship | Some | 1 | |
| Netupitant 300 mg and palonosetron (as palonosetron hydrochloride) 500 microgram oral capsule | Has presentation strength numerator unit | mcg | true | Inferred relationship | Some | 1 | |
| Netupitant 300 mg and palonosetron (as palonosetron hydrochloride) 500 microgram oral capsule | Has presentation strength denominator unit (attribute) | Capsule (unit of presentation) | true | Inferred relationship | Some | 1 | |
| Netupitant 300 mg and palonosetron (as palonosetron hydrochloride) 500 microgram oral capsule | Has precise active ingredient | Netupitant (substance) | true | Inferred relationship | Some | 2 | |
| Netupitant 300 mg and palonosetron (as palonosetron hydrochloride) 500 microgram oral capsule | Has basis of strength substance (attribute) | Netupitant (substance) | true | Inferred relationship | Some | 2 | |
| Netupitant 300 mg and palonosetron (as palonosetron hydrochloride) 500 microgram oral capsule | Has presentation strength numerator unit | mg | true | Inferred relationship | Some | 2 | |
| Netupitant 300 mg and palonosetron (as palonosetron hydrochloride) 500 microgram oral capsule | Has presentation strength denominator unit (attribute) | Capsule (unit of presentation) | true | Inferred relationship | Some | 2 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Reference Sets
FHIR